EDGAR Filing Documents for 0001654954-24-008177

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001654954-24-008177

Filing Date

2024-06-25

Accepted

2024-06-25 16:09:11

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA 14A	shn_defa14a.htm	DEFA14A	9487
2		shn_defa14aimg1.jpg	GRAPHIC	154366
3		shn_defa14aimg2.jpg	GRAPHIC	166975
	Complete submission text file	0001654954-24-008177.txt		453387

Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105

Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468

ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37969 | Film No.: 241069018
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)